Photo of Celina Ang

Celina Ang

  • ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile


  • Medical Oncology

  • American Board of Internal Medicine

Clinical Focus


  • MD, University of Western Ontario

  • B.Sc., McGill University

  • Residency, Internal Medicine
    Montreal General Hospital

  • Fellowship, Oncology
    McGill University

  • Fellowship, Gastrointestinal Oncology
    Memorial Sloan-Kettering Cancer Center


    I am a medical oncologist who specializes in the care of patients with gastrointestinal malignancies.  My research interests focus on the investigation of new therapies for these diseases, particularly cancers of the liver and biliary system.


  • 2011 - 2012
    Clinical training and research grant
    Fibrolamellar Cancer Foundation

  • 2010 - 2011
    Montreal General Hospital Foundation Research Award

  • 2003 -
    Dr. L. DeWitt Wilcox Award in Medical Research
    Schulich School of Medicine & Dentistry, The University of Western Ontario

  • 1997 - 2001
    James McGill Entrance Scholarship
    McGill University


Ang C, Chambers AF, Tuck AB, Winquist E, Izawa JI. Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder. BJU international 2005 Nov; 51(6).

Ang C, Guiot MC, Ramanakumar AV, Roberge D, Kavan P. Clinical significance of molecular biomarkers in glioblastoma.. Can J Neurol Sci 2005 Oct; 37(5): 625-30.

Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T. Characteristics and outcomes of medulloblastoma in adults. Pediatric blood & cancer 2008 Feb; 51(5).

Ang C, Kornbluth M, Thirlwell M, Rajan R. Capecitabine-induced cardiotoxicity: case report and review of the literature. Current oncology (Toronto, Ont.) 2010 Sep; 17(1).

Cohen V, Agulnik J, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, Miller WH. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors. Can J Neurol Sci 2010 Sep; 37(18).

Ang C, O'Reilly EM, Abou-Alfa GK, Shamseddine A, Skouri H, Tawil A, Eloubeidi MA, Lowery M, Kharfan-Dabaja M, Kaprealian T, Temraz S, Sibai H, Farran H, Shah MA. Gastrointestinal cancer educational case series: management of metastatatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor.. J Gastrointest Cancer 2011 Sep; 42(3): 165-70.

Postow M, Shah MA, Lowery M, Shamseddine A, El-Kutoubi A, Al Olayan A, Naghy M, Ang C, Tamraz S, Jazieh AR, O'Reilly EM, Kelsen DP, Abou-Alfa GK. A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. Journal of gastrointestinal cancer 2012 Jun; 43(2).

Ang C, O'Reilly EM, Abou-Alfa GK. MicroRNA, hypoxic stress and hepatocellular carcinoma: future directions [editorial]. J Gastroenterol Hepatol 2011 Nov; 26(11): 1686-8.

Ang C, Janjigian YY, Shamseddine A, Tawil A, Lowery MA, Intlekofer A, Faraj W, Al-Olayan A, Tang L, O'Reilly EM, Geara F, Al-Kutoubi A, Kelsen DP, Abou-Alfa GK. A case of advanced gastric cancer. Gastrointestinal cancer research : GCR 2012 Mar; 5(2).

Ang C, O'Reilly EM, Abou-Alfa GK. Targeted agents and systemic therapy in hepatocellular carcinoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progr├Ęs dans les recherches sur le cancer 2013; 190.

Ang C, Kemeny NE. Bevacizumab in the management of colorectal cancer: a review.. Journal of Solid Tumors 2011:120-131.

Abou-Alfa GK, Ang C. Dx/Rx Liver Cancer 1st Edition. Burlington, MA, Jones & Bartlett Learning;.

Ang C, Abu-Alfa AK, Abdullah K, Lowery M, Sibai H, El Farran H, Tamraz S, Al Olayan A, Shamseddine A, Naghy M, Faraj W, O'Reilly EM, Abou-Alfa GK. Hepatocellular carcinoma following renal transplantation. Gastrointestinal cancer research : GCR 2011 Sep; 4(5-6).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Ang did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Annenberg Building Floor 24th Room 24-04D
1468 Madison Avenue
New York, NY 10029

Ruttenberg Treatment Center

1470 Madison Avenue
3rd floor
New York, NY 10029

Tel: 212-241-6756
Fax: 646-537-9639
Get Directions
Insurance Plans
  • 1199
  • Access Medicare
  • Aetna
  • Affinity
  • Amerigroup
  • AmidaCare
  • Cigna - HMO
  • Empire Blue Cross/Blue Shield - PPO
  • Fidelis Care NY
  • GHI
  • Health Insurance Plan (HIP)
  • Health Republic
  • HealthFirst
  • Island Group
  • Magnacare
  • Medicaid of New York
  • Medicare
  • MetroPlus Health Plan
  • MultiPlan, Inc.
  • Oscar Insurance
  • Oxford Health Plans
  • Pomco
  • United Healthcare
  • VNS Medicare
  • WellCare of New York, Inc.
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Discover
  • Personal Check
  • Cash